Clinical pharmacokinetics and pharmacodynamics of venetoclax, a selective B‐cell lymphoma‐2 inhibitor by Ahmed Hamed Salem, Rajeev M. Menon

Connect to this object online.

Model‐Informed Dosing of Venetoclax in Healthy Subjects: An Exposure−Response Analysis by Nimita Dave, Sathej Gopalakrishnan, Sven Mensing, Ahmed Hamed Salem

Connect to this object online.

Power Determination During Drug Development: Is Optimizing the Sample Size Based on Exposure‐Response Analyses Underutilized? by Aksana K. Jones, Ahmed Hamed Salem, Kevin J. Freise

Connect to this object online.

Semimechanistic Modeling to Guide Venetoclax Coadministration with Ritonavir and Digoxin by Ali A. Alhadab, Ahmed Hamed Salem, Kevin J. Freise

Connect to this object online.

A microdosing framework for absolute bioavailability assessment of poorly soluble drugs: A case study on cold‐labeled venetoclax, from chemistry to the clinic by Amr Alaarg, Rajeev Menon, David Rizzo, Yemin Liu, Jeffrey Bien, Tricia Elkinton, Timothy Grieme, Lutz R. Asmus, Ahmed Hamed Salem

Connect to this object online.

A Critical Review of Chloroquine and Hydroxychloroquine as Potential Adjuvant Agents for Treating People with Cancer by Amal Kamal Abdel-Aziz, Mona Kamal Saadeldin, Ahmed Hamed Salem, Safaa A. Ibrahim, Samia Shouman, Ashraf B. Abdel-Naim, Roberto Orecchia

Connect to this object online.